A new American College of Physicians clinical practice guideline states asymptomatic adults without risk factors should not routinely be screened for chronic kidney disease. That recommendation differs from those adopted by the AAFP and the U.S. Preventive Services Task Force last year, in which both groups concluded there was insufficient evidence to assess the benefits and harms of routine CKD screening in asymptomatic adults. The ACP guideline did recommend statin therapy to help control cholesterol and an angiotensin-converting enzyme inhibitor or angiotensin II–receptor blocker to help control hypertension in patients with stage 1 to 3 chronic kidney disease.

Full Story:

Related Summaries